Clinical Trials Logo

Filter by:
NCT ID: NCT04729387 Active, not recruiting - Ovarian Cancer Clinical Trials

Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected

Start date: July 2, 2021
Phase: Phase 3
Study type: Interventional

The objective of this study is to assess the efficacy and safety of the combination of alpelisib and olaparib compared with single agent cytotoxic chemotherapy in patients with platinum resistant or refractory high-grade serous ovarian cancer, with no germline BRCA mutation detected.

NCT ID: NCT04729322 Active, not recruiting - Clinical trials for Stage IV Colorectal Cancer AJCC v8

Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders

Start date: February 22, 2021
Phase: Phase 2
Study type: Interventional

This phase II trial studies the effect of fecal microbiota transplant and re-introduction of anti-PD-1 therapy (pembrolizumab or nivolumab) in treating anti-PD-1 non-responders with colorectal cancer that has spread to other places in the body (metastatic). Fecal microbiota transplants contain the normal bacteria and viruses found in fecal (stool) material. Immunotherapy with monoclonal antibodies, such as pembrolizumab and nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab or nivolumab with fecal microbiota transplants may help to control the disease.

NCT ID: NCT04728295 Active, not recruiting - Parkinson Disease Clinical Trials

Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD)

Start date: May 14, 2021
Phase: N/A
Study type: Interventional

Evaluate the Safety and Effectiveness of Staged Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD).

NCT ID: NCT04727788 Active, not recruiting - Clinical trials for Kidney Transplant Rejection

Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection

Start date: March 21, 2021
Phase:
Study type: Observational

Global, non-randomized, observational study for the validation of Verici Dx genomic tests to predict risk of kidney clinical and subclinical acute rejection, and chronic allograft damage or interstitial fibrosis / tubular atrophy by correlating peripheral blood gene expression profiles with graft injury (e.g. cellular / antibody-mediated), rejection and death censored graft loss.

NCT ID: NCT04727216 Active, not recruiting - Pain, Chronic Clinical Trials

Intermittent vs. Continuous Dorsal Root Ganglion Stimulation

Start date: March 23, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate and compare the therapeutic efficacy of intermittent Dorsal Root Ganglion Stimulation (DRG-S) to standard continuous stimulation in patients with chronic intractable pain

NCT ID: NCT04727099 Active, not recruiting - Wrinkle Clinical Trials

Clinical Evaluation to Demonstrate the Safety and Performance of the Candela PicoWay System™

Start date: September 28, 2020
Phase: N/A
Study type: Interventional

This study is intended to demonstrate the safety and efficacy of the PicoWay™ Laser System for its intended uses: clearance of benign pigmented lesions and improvement in appearance of wrinkles.

NCT ID: NCT04726852 Active, not recruiting - Clinical trials for Myocardial Contraction

Arterial Pressure vs. TE Echo dp/dt

Start date: February 2, 2021
Phase:
Study type: Observational

This study seeks to assess the strength of correlation between arterial pressure waveform derived contractility as quantified by the maximal rate of pressure change ans a function of time (dp/dtmax) and transesophageal echocardiographically (TEE) determined contractility, also quantified by dp/dtmax. In addition, correlations between dp/dtmax. In addition, TEE derived assessment of ejection fraction will provide guidance for relating this new parameter with other standard contractility assessments.

NCT ID: NCT04726293 Active, not recruiting - Healthy Clinical Trials

Anti-inflammatory Effect and Associated Mechanisms of Mango Consumption

MG2
Start date: February 22, 2021
Phase: N/A
Study type: Interventional

The primary objective of this project is to provide new knowledge through a comprehensive set of analyses that investigate the complex interplay between regular mango intake, gut microbial structure/ function, mechanisms of inflammation and insulin sensitivity in over weight (OW)/obese (OB) human subjects with chronic low-grade inflammation.

NCT ID: NCT04725643 Active, not recruiting - Contraception Clinical Trials

Keep Contraceptive Arm Long Acting-iMplant (CALM) and Carry On

CALM
Start date: February 17, 2022
Phase:
Study type: Observational

The investigators will conduct an observational study comparing the number of bleeding days before and after contraceptive implant (Nexplanon) replacement.

NCT ID: NCT04725513 Active, not recruiting - Clinical trials for Achilles Tendinopathy

Pilot Investigation to Evaluate Effectiveness of Shockwave Therapy, Photobiomodulation and Physical Therapy in the Management of Non-insertional Achilles Tendinopathy

Start date: August 29, 2022
Phase: N/A
Study type: Interventional

This is a randomized control trial with an elective cross over after three months to evaluate three different treatments in the management of non-insertional Achilles Tendinopathy. The treatment methods include physical therapy, shockwave therapy and photobiomodulation.